XT
ERNA icon

XTX Topco’s Eterna Therapeutics ERNA Stock Holding History

XTX Topco’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8K Buy
+2,174
New +$34.7K ﹤0.01% 3674
2025
Q2 		– Sell
-110
Closed -$7.37K – 2572
2025
Q1 		$7.37K Sell
110
-45
-29% -$5.55K ﹤0.01% 2279
2024
Q4 		$17.1K Buy
+155
New +$42K ﹤0.01% 2065

Other funds holding ERNA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's ERNA Position: Q1 2026 in Review

XTX Topco opened a new position in Eterna Therapeutics (ERNA) in Q1 2026: 2,174 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #3674 among its holdings. This is a return to the name: XTX Topco previously reported a position in ERNA as recently as Q1 2025.

XTX Topco first reported a position in ERNA in Q4 2024 and has held it in 3 quarters since. The position peaked at $17.1K in Q4 2024. 15 funds tracked by Wall St. Rank hold ERNA as of Q1 2026.

  • XTX Topco held 2,174 shares of Eterna Therapeutics worth $10.8K as of Q1 2026.
  • Eterna Therapeutics was a new XTX Topco position in Q1 2026.
  • Eterna Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3674 holding.
  • XTX Topco first reported a position in Eterna Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • XTX Topco's Eterna Therapeutics position peaked at $17.1K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.